Navigation Links
Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
Date:7/30/2008

in listening to the live webcast should log on before the conference call begins to download any software required. Both the audio replay and the archive of the conference call webcast will remain available for several days.

ABOUT HUMAN GENOME SCIENCES

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa-2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of inhalation anthrax, and the Company is on track to begin the delivery in fall 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. HGS also has three drugs in clinical development for the treatment of cancer, including two TRAIL receptor antibodies and a small-molecule antagonist of IAP (inhibitor of apoptosis) proteins. In addition, HGS has substantial financial rights to three products in the GSK clinical development pipeline.

For more information about HGS, please visit the Company's web site at http://www.hgsi.com. Health professionals and patients interested in clinical trials of HGS products may inquire via e-mail to clinical_trials@hgsi.com or by calling HGS at (301) 610-5790, extension 3550.

HGS, Human Genome Sciences, ABthrax, Albuferon and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

SAFE HARBOR STATEMENT

This announcement contains forward-looking statements within the me
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
2. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
3. New map IDs the core of the human brain
4. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
5. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
6. China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
7. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
8. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
9. Robots moving closer to humans
10. Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes
11. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...eland,November24/PRNewswire-FirstCall/--deCODE,gen...ofallofits,"firstday"motionsbytheU.S.BankruptcyCou...deCODElastweekfiledavoluntarypetitionfor,reliefund...BankruptcyCourt. , TheordersissuedbytheBankru...inessduringtheChapter11proceedings.Inparticular,th...
(Date:11/24/2009)....24/PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,...provedthe,investigationalnewdrugapplication(IND)fo...nformulationtotreatdiabetes.ThisIND,approvalallows..., Diabetesisadisordercharacteristicofhighbloodglu...ftenresultinseveremicro-and,macro-vasculardiseases...
(Date:11/24/2009)...acyendpointhasbeenmetforpatientswithadvanced-stage...ov.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NA...aceuticalcompanyfocusedonendocrinetherapyandoncolo...udywithitstargetedcytotoxicpeptideconjugate,AEZS-1...ntendometrialcancer.Inapersonalizedhealthcareappro...
(Date:11/24/2009)....24,2009/PRNewswire-FirstCall/--ArenaPharmaceutica...nyisscheduledtopresentatthePiperJaffray21stAnnualH...ernTime(8:30a.m.PacificTime)attheNewYorkPalaceHote...ExecutiveOfficer,isscheduledtoprovideanoverviewoft...eryprograms. ,, Aliveaudiowebcastofthepresentat...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...dge University have discovered that freshwater alg...round each other, miraculously held together only ...as published today in the journal Physical Review...llular organism Volvox, which consists of approxim...erical matrix about half a millimetre in diameter....
...dle (Nasdaq: KNDL ), a leading, global full-serv...d that it will not meet analyst expectations for t...the impact of unprecedented biopharmaceutical indu...ays in the signing of contracts on existing awards... in contract cancellations and delays. The Company...
...bcast Scheduled -- , , BRISBANE, Calif., April 20...d that InterMune and Pharmasset, Inc. will host a ...ts from the EASL conference on Saturday, April 25,...pating in the discussion will be Ed Gane, M.D., pr...rs of management from Roche, InterMune and Pharmas...
Other Biology Technology:Scientists discover 'dancing' algae 2Kendle to Host Conference Call to Discuss Revised 2009 Outlook 2Kendle to Host Conference Call to Discuss Revised 2009 Outlook 3InterMune and Pharmasset to Discuss INFORM-1 Results From EASL Conference, April 25 2
(Date:11/24/2009)...hat constitutes fish food is a matter of debate. A... fish get almost 50 percent of their carbon from t...tween the terrestrial and aquatic ecosystems. , ... shows this is not likely to be true. Algae provid...fe, according to research published this week in t...
(Date:11/23/2009)...shington, D.C. The community-associated strain of...eria resistant to most common antibioticsposes a f... is making its way into hospitals, according to a ...s Diseases . , The new threat is easily picked ...laces and has increased the overall burden of MRSA...
(Date:11/23/2009)...VINE, Calif. -- More than 160 participants gathere...ies Keck FUTURES INITIATIVE conference. This year,...entists, engineers, and medical researchers to exp...s surrounding the emerging field of synthetic biol... biology at Princeton University and this year,s c...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Researchers find genetic link between physical pain and social rejection 9593 1Researchers find genetic link between physical pain and social rejection 9593 2Researchers find genetic link between physical pain and social rejection 9593 3Its Backpack Safety Time 54643 1Its Backpack Safety Time 54643 2Planet Fitness Soars to Inc 500 54641 1Planet Fitness Soars to Inc 500 54641 2
...INGTON, Conn., Jan. 7 Accu-Time Systems, Inc., th...me and attendance, and,security access products, t...uman Capital Management (HCM) solution, Maximus(TM...mus is a state-of-the-art human resources Internet...obsolete by removing limitations through,the use o...
...Claims that tropical forests are declining cannot ...search from the University of Leeds. , This major...ing finding of a study published today in the Proc...Dr Alan Grainger, Senior Lecturer in Geography and...forestation. , "Every few years we get a new esti...
...People who adopt four healthy behaviours not smok... eating five servings of fruit and vegetables a da... life compared with people who adopt none of these... open access journal PLoS Medicine. , Rather tha...to health, the study calculates the combined impac...
Other Biology News:Accu-Time Systems, Inc. Announces Launch of Next Generation Human Capital Management (HCM) solutions: Global Series(TM) 2No convincing evidence for decline in tropical forests 2No convincing evidence for decline in tropical forests 34 health behaviors can add 14 extra years of life 2
Goat Anti-Wnt2 Polyclonal Antibody, Unconjugated from MBL International
Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter
Mynox Mycoplasma Elimination Reagent from Sigma-Aldrich
Acridinium NHS ester from Cayman Chemical
Biology Products: